on a mobile?
vTap
    Loading...
 
suggest
Sanofi-Aventis
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Sanofi-Aventis
Go to Feed to see what's new!
+Feed
 
Refine
The M100 move to Sanofi-Aventis.
10 months ago
Forbes
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Sanofi-Aventis
Go to Feed to see what's new!
share
keep
 
 
9270
Natco Pharma has cracked the technology to develop Teva's multiple sclerosis drug Copaxone, which has US sales of over USD 2 billion, reports CNBC-TV18. The drug is marketed by Sanofi Aventis. Natco ...
a year ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Glatiramer acetate
Sanofi-Aventis
Pharmaceutical company
Teva Pharmaceutical Industries
CNBC-TV18
Multiple sclerosis
United States dollar
CNBC
Go to Feed to see what's new!
share
keep
 
 
Pharmaceutical companies Sanofi Pasteur and Glaxo Smithkline have been charged with "aggravated deception". The firms are accused over dangers linked to Hepatitis B vaccinations.
a year ago
France 24
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Vaccination
Sanofi pasteur
Hepatitis B
GlaxoSmithKline
Sanofi-Aventis
Pharmaceutical company
Corporate law
Hepatitis
Louis Pasteur
United Kingdom
Go to Feed to see what's new!
share
keep
 
 
Jun. 19 - Home Depot sheds some weight, and drug-makers secure victory with a U.S. judge. Drug-makers Bristol Myers-Squibb and Sanofi-Aventis won a patent challenge over a multi-billion dollar drug. ...
2 years ago
Reuters
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Bristol-Myers Squibb
Best Buy
The Home Depot
Sanofi-Aventis
United States
Go to Feed to see what's new!
share
keep
 
 
A Food and Drug Administration panel unanimously rejected a weight-loss drug from Sanofi-Aventis, on concerns the drug increases the number of psychiatric events like depression and suicidal thinking ...
2 years ago
Associated Press
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Sanofi-Aventis
Weight loss
Anti-obesity drug
Drug abuse
Clinical depression
Go to Feed to see what's new!
share
keep
 
 
Drug manufacturer Sanofi-Aventis says people suffering from depression should not take the weight-loss drug rimonabant; the FDA is expected to decide whether rimonabant can be sold in the U.S. by the ...
2 years ago
Associated Press
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Sanofi-Aventis
United States
Weight loss
Anti-obesity drug
Clinical depression
Go to Feed to see what's new!
share
keep
 
 
Louis Aronne, an obesity specialist at New York-Presbyterian Hospital who has consulted for Sanofi-Aventis SA, talks with Bloomberg's Mike Schneider from Washington about Sanofi's Acomplia weight-...
2 years ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
United States
Sanofi-Aventis
Weight loss
Anti-obesity drug
NewYork-Presbyterian Hospital
Presbyterian
Washington, D.C.
Mike Schneider
Go to Feed to see what's new!
share
keep
 
 
David Stout, chief operating officer of GlaxoSmithKline Plc, talked with Bloomberg's Deborah Kostroun yesterday about the outlook for the company's Tykerb breast cancer pill and flu vaccine. The U.S. ...
2 years ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Flu vaccine
GlaxoSmithKline
Sanofi-Aventis
Lapatinib
Breast cancer
Combined oral contraceptive pill
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use